Time to Invest in Sickle Cell Anemia as a Global Health Priority.

DOI: 10.1542/peds.2016-0348 Accepted for publication Mar 16, 2016 Address correspondence to Patrick T. McGann, MD, MS, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229. E-mail: [email protected] PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 10984275). Copyright © 2016 by the American Academy of Pediatrics FINANCIAL DISCLOSURE: The author has indicated he has no fi nancial relationships relevant to this article to disclose. FUNDING: This work was supported by the National Heart, Lung, and Blood Institute Award K23-HL128885-01. The content is solely the responsibility of the authors and does not necessarily represent the offi cial views of the National Institutes of Health. Funded by the National Institutes of Health (NIH). POTENTIAL CONFLICT OF INTEREST: The author has indicated he has no potential confl icts of interest to disclose. More than 500 children with sickle cell anemia (SCA) die every single day because of lack of access to early diagnosis and associated treatment, yet SCA remains an invisible global health problem.